Depression and Anxiety Trial, Recruiting NCT04836936 Sponsor: Jacques E. Chelly Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT04836936
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who are scheduled to have a planned surgery to remove part or all of one kidney
  • People who are willing and able to give their formal agreement to take part in the study
  • People who score between 19 and 29 on a specific anxiety measurement questionnaire called the PROMIS Emotional Distress-Anxiety-Short Form 8a (confirm with trial site for details on this assessment)

Who may not be able to join:

  • People who have a diagnosis of opioid use disorder, as defined by standard medical diagnostic guidelines
  • People who have a long-term pain condition that requires them to take opioid pain medications every day
  • People who have a history of fibromyalgia (a condition causing widespread body pain and fatigue)
  • People who have an abnormal ear structure, whether present from birth or caused by an injury
  • People who have a condition affecting blood vessel function in the ear
  • People who have Raynaud's disease (a condition where blood flow to certain parts of the body, such as fingers and toes, is reduced in response to cold or stress)
  • People who do not wish to participate

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jacques E Chelly, MD, University of Pittsburgh

Phone: 412-623-6382

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jacques E. Chelly
Registry
ClinicalTrials.gov
Start date
13 April 2021
Est. completion
30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Opioid Consumption

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov